Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx) - GlobeNewswire

1. Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx)  GlobeNewswire
2. After leadership shuffle, Akcea hands heart drug to Pfizer for $250M  FierceBiotech
3. Here's Why Akcea Therapeutics Jumped 30% Today  The Motley Fool
4. Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B  Genetic Engineering & Biotechnology News
5. What Happened in the Stock Market Today  Motley Fool
6. View full coverage on Google News

by via Top stories - Google News